2018 / 01

Next Paper
DOI: 10.24075/brsmu.2018.008

ORIGINAL RESEARCH

Analysis of the association between the RS767455 T>C TNFRSF1A and RS1061622 T>G TNFRSF1B polymorphisms and nonalcoholic steatohepatitis

Topchieva LV1, Kurbatova IV1, Dudaniva OP2, Shipovskaya AA2
About authors

1 Institute of Biology, Karelian Research Center of RAS, Petrozavodsk, Republic of Karelia

2 Institute of Medicine, Petrozavodsk State University, Petrozavodsk, Republic of Karelia

Correspondence should be addressed: Ludmila Topchieva
ul. Pushkinskaya 11, Petrozavodsk, 198910; ur.liam@76aveihcpot

About paper

Funding: this study was part of the public contract 0221-2017-0049 and was carried out using the equipment of the shared facility Complex Basic and Applied Research of Living Systems in the Arctic of the Institute of Biology, Karelian Research Center. The work was also sponsored by a scholarship of the President of the Russian Federation for young scientists and graduate students engaged in advanced research and development in priority areas of modernization of the Russian economy in 2015-2017 years. The authors also received support from Petrozavodsk State University as part of the efforts for its strategic development in 2013– 2017 (R&D 115070110006, Information reference map 216022450003, registered February 24, 2016) under the project for the Development of Technologies for Diagnostic Screening for Nonalcoholic Fatty Liver Disease in Overweight Patients and Patients with Metabolic Syndrome (ID 9173GU/2015 dated December 15, 2015) of the UMNIK program.

Received: 2017-10-31 Accepted: 2018-03-02 Published online: 2018-04-15
|
  1. Lebensztejn DM, Kowalczuk D, Tarasów E, Skiba E, Kaczmarski M. Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD. Adv Med Sci. 2010; 55 (1): 74–9. PubMed PMID: 20371430. DOI: 10.2478/v10039-010- 0008-5.
  2. Bocsan IC, Milaciu MV, Pop RM, Vesa SC, Ciumarnean L, Matei DM et al. Cytokines genotype-phenotype correlation in nonalcoholic steatohepatitis. Oxid Med Cell Longev. 2017; 2017:4297206. Epub 2017 Aug 9. PubMed PMID: 28852433. DOI: 10.1155/2017/4297206.
  3. Braunersreuther V, Viviani GL, Mach F, Montecucco F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2012; 18: 727–35. PubMed PMID: 22371632. DOI: 10.3748/wjg.v18.i8.727.
  4. Lee Y-M, Sutedja DS, Wai C-T, Dan Y-Y, Aung M-O, Zhou L et al. A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH). Hepatol Int. 2008; 2 (2): 196–201. PubMed PMID: 19669304. DOI: 10.1007/s12072- 008-9058-1.
  5. Kakino S, Ohki T, Nakayama H, Yuan X, Otabe S, Hashinaga T et al. Pivotal role of TNF-α in the development and progression of nonalcoholic fatty liver disease in a murine model. Horm Metab Res. 2017 Sep 18. [Epub ahead of print]. PubMed PMID: 28922680. DOI: 10.1055/s-0043-118666.
  6. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001; 104: 487–501. PubMed PMID: 11239407.
  7. Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cellular Signalling. 2012; 24: 1297–1305. PubMed PMID: 22374304. DOI: 10.1016/j.cellsig.2012.02.006.
  8. DeBerge MP, Ely KH, Wright PF, Thorp EB, Enelow RI. Shedding of TNF receptor 2 by effector CD8+ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection. JLeukocBiol. 2015; 98: 423–34. PubMed PMID: 26019295. DOI: 10.1189/jlb.3A0914-432RR.
  9. Levitan BN, Astahin AV, Levitan GB. Faktor nekroza opuholej i ego rastvorimye receptory II tipa pri hronicheskih gepatitah i cirrozah pecheni. Jeksperimental'naja i klinicheskaja gastrojenterologija. 2017; 2: 62-6. Russian.
  10. Lin SY, Wang YY, Sheu WH. Increased serum leptin concentration correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis. Clinical Endocrinol (Oxf). 2002; 57: 805– 11. PubMed PMID: 12460331.
  11. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adipo¬nectin? Hepatology. 2004; 40: 46–54. PubMed PMID: 15239085.
  12. Tokushige K, Takakura M, Tsuchiya-Matsushita N, Taniai M, Hashimoto E, Shiratori K. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol. 2007; 46: 1104–10. PubMed PMID: 17395331. DOI: 10.1016/j. jhep.2007.01.028.
  13. Tarrats N, Moles A, Morales A, García-Ruiz C, Fernández-Checa JC, Marí M. Critical role of tumor necrosis factor receptor 1, but not 2, in hepaticstellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis. Hepatology. 2011; 54: 319– 27. PubMed PMID: 21523796. DOI: 10.1002/hep.24388.
  14. Ijiri Y, Katoa R, Sadamatsua M, Takano M, Okadac Y, Tanaka K et al. Chronological changes in circulating levels of soluble tumor necrosis factor receptors 1 and 2 in rats with carbon tetrachloride-induced liver injury. Toxicology. 2014; 316: 55–60 PubMed PMID: 24389507. DOI: 10.1016/j.tox.2013.12.004.
  15. Sorg U, Behnke K, Degrandi D, Reich M, Keitel V, Herebian D, et al. Cooperative role of lymphotoxin b receptor and tumor necrosis factor receptor p55 in murine liver regeneration. Journal of Hepatology. 2016; 64: 1108–17. PubMed PMID: 26708145. DOI: 10.1016/j.jhep.2015.12.006.
  16. Lana JP, Martins LB, Oliveira MC, Menezes-Garcia Z, Yamada LT, Vieira LQ et al. TNF and IL-18 cytokines may regulate liver fat storage under homeostasis conditions. Appl Physiol Nutr Metab. 2016; 41: 1295–1302. PubMed PMID: 27863204. DOI: 10.1139/ apnm-2016-0265.
  17. Sennikov SV, Vasilyev FF, Lopatnikova JA, Shkaruba NS, Silkov AN. Polymorphisms in the tumor necrosis factor receptor genes affect the expression levels of membrane-bound type I and type II receptors. Mediators Inflamm. 2014; 2014:745909. Epub 2014 Mar 24. PubMed PMID: 24782596. DOI: 10.1155/2014/745909.
  18. Wang J, Ni H, Chen L, Liu YX, Chen CB, Song WQ. Preparation and analysis of cSNP chip on hepatocellular carcinoma-related genes. Hepatobiliary Pancreat Dis Int. 2005; 4: 398–402. PubMed PMID: 16109524.
  19. Machado MV, Martins A, Almeida R, Marques-Vidal P, Gonçalves MS, Camilo ME et al. Does the simultaneous tumor necrosis factor receptor 2, tumor necrosis factor promoter gene polymorphism represent a higher risk for alcoholic liver disease? Eur J Gastroenterol Hepatol. 2009; 21: 201–5. PubMed PMID: 19212208. DOI: 10.1097/MEG.0b013e32831016e0.
  20. Liu X, Invernizzi P, Lu Y. Kosoy R, Lu Y, Bianchi I et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet. 2010; 42: 658–60. PubMed PMID: 20639880. DOI: 10.1038/ng.627.
  21. Xu F, Zhou G, Han S, Yuan W, Chen S, Fu Z et al. Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women. PloS One. 2014; 9 (7): e101138. PubMed PMID: 25010932. DOI: 10.1371/journal.pone.0101138.
  22. Fletcher R. Klinicheskaja jepidemiologija. M.: Izd-vo «Media- Sfera»; 1998. 352 p. Russian.
  23. Glossop JR, Dawes PT, Nixon NB, Mattey DL. Polymorphism in the tumor necrosis factor receptor II gene is associated with circulating levels of soluble tumor necrosis factor receptors in rheumatoid arthritis. Arthritis Research & Therapy. 2005; 7: 1227– 34. PubMed PMID: 16277675. DOI: 10.1186/ar1816.
  24. Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C. Silent (synonymous) SNPs: should we care about them? Methods Mol Biol. 2009; 578: 23–39. PubMed PMID: 19768585. DOI: 10.1007/978-1-60327-411-1-2.
  25. Matsukura H, Ikeda S, Yoshimura N, Takazoe M, Muramatsu M. Genetic polymorphisms of tumor necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease. Aliment Pharmacol Ther. 2008; 27: 765–70. PubMed PMID: 18248655. DOI: 10.1111/j.1365- 2036.2008.03630.x.
  26. Rittore C, Sanchez E, Soler S, Albers M, Obici L et al. Grandemange SOR10-002 - A novel TNFR1 transcript of TRAPS gene. Pediatr Rheumatol Online J. 2013; 11: A186. PMCID: PMC3953180. DOI: 10.1186/1546-0096-11-S1-A186.
  27. Tolusso B, Sacco S, Gremese E, La Torre G, Tomietto P, Ferraccioli GF. Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis. Hum Immunol. 2004; 65 (12): 1420–6. PubMed PMID: 15603867. DOI: 10.1016/j.humimm.2004.06.010.
  28. Stark GL, Dickinson AM, Jackson GH, Taylor PR, Proctor SJ, Middleton PG. Tumor necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels innormal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation. Transplantation. 2003; 76: 1742–49. PubMed PMID: 14688526. DOI: 10.1097/01. TP.0000092496.05951.D5.
  29. Crespo J, Cayón A, Fernández-Gil P, Hernández-Guerra M, Mayorga M, Domínguez-Díez A et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic ste¬atohepatitis patients. Hepatology. 2001; 34: 1158–63. PubMed PMID: 11732005.
  30. Cubillas R, Kintner K, Phillips F, Karandikar NJ, Thiele DL, Brown GR. Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy. Hepat Res Treat. 2010; 2010:429243. PMCID: PMC2989713. DOI: 10.1155/2010/429243.
  31. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 1996; 7: 231–240. PubMed PMID: 8971478.
  32. Till A, Rosenstiel P, Krippner-Heidenreich A, Mascheretti-Croucher S, Croucher PJ, Schäfer H et al. The Met196Arg variation of human TNFR2 affects TNF alpha induced apoptosis by impaired NF-κB-signalling and target gene expression. J Biol Chem. 2005; 280: 5994–6004. PubMed PMID: 15572357, DOI: 10.1074/jbc.M411541200.
  33. Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev. 2010; 90: 1165–1194. PubMed PMID: 20664081.
  34. Morita C, Horiuchi T, Tsukamoto H, Hatta N, Kikuchi Y, Arinobu Y et al. Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis. Arthritis Rheum. 2001; 44 (12): 2819–27. PubMed PMID: 11762942.